Microbot Medical (MBOT) Equity Average (2011 - 2026)

Microbot Medical has reported Equity Average for 16 years, with the latest figure at $75.8 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 366.92% year-over-year to $75.8 million; the trailing twelve-month figure through Mar 2026 stood at $75.8 million (up 366.92% YoY), and the FY2025 full-year result was $40.5 million, up 909.64% from the prior year.
• Equity Average for Q1 2026 stood at $75.8 million, down from $77.9 million in the prior quarter.
• The five-year high for Equity Average was $77.9 million in Q4 2025, with the low at $3.7 million in Q4 2024.
• Historically, Equity Average has averaged $19.9 million across 5 years, with a median of $7.2 million in 2023.
• Annual changes were most pronounced in 2022 — Equity Average plunged 62.95% — and 2025, when it surged 2022.89%.
• Microbot Medical's Equity Average stood at $6.4 million in 2022, then dropped by 7.51% to $5.9 million in 2023, then slumped by 38.12% to $3.7 million in 2024, then surged by 2022.89% to $77.9 million in 2025, then fell by 2.64% to $75.8 million in 2026.
• The last three Equity Average figures came in at $75.8 million (Q1 2026), $77.9 million (Q4 2025), and $54.3 million (Q3 2025), per Business Quant data.